BRIEF published on 08/01/2025 at 14:05, 1 year 1 month ago CARMAT: Resumption of Quotation and Update on Judicial Recovery Takeover Offer CARMAT Resumption Of Quotation Judicial Recovery Aeson® Artificial Heart
BRIEF published on 07/01/2025 at 20:50, 1 year 2 months ago Half-yearly report on CARMAT's liquidity contract Liquidity Contract Actions CARMAT Judicial Recovery Stockbroker
BRIEF published on 06/20/2025 at 19:15, 1 year 2 months ago CARMAT launches a donation campaign in the face of a financial crisis Funding Heart Failure Artificial Heart Financial Crisis Donation Campaign
PRESS RELEASE published on 06/20/2025 at 19:10, 1 year 2 months ago Inside Information / Other news releases CARMAT launches a donation campaign to address critical financial situation and risk of insolvency. The initiative aims to secure urgent funding for its innovative total artificial heart Financial Situation CARMAT Artificial Heart Donation Campaign Risk Of Insolvency
BRIEF published on 06/04/2025 at 17:50, 1 year 3 months ago CARMAT: Terms and conditions for the General Meeting of June 26, 2025 General Assembly Remote Voting CARMAT Artificial Heart Financial Risks
BRIEF published on 06/02/2025 at 07:05, 1 year 3 months ago CARMAT makes its first sales of artificial hearts in Israel CARMAT European Union Israel Aeson® Locations
BRIEF published on 04/09/2025 at 17:50, 1 year 4 months ago CARMAT Achieves Strong Q1 2025 Results CARMAT Q1 2025 FDA Discussions Aeson® Implants EFICAS Trial
PRESS RELEASE published on 04/09/2025 at 17:45, 1 year 4 months ago Inside Information / Other news releases CARMAT delivers strong Q1 2025 results with €2.4m sales, progresses EFICAS trial, and advances FDA discussions for EFS study in the US. Aiming for long-term patient support with enhanced heart by end of 2025 CARMAT Long-term Support FDA Discussions Q1 2025 Results EFICAS Trial
BRIEF published on 02/17/2025 at 07:05, 1 year 6 months ago CARMAT's Aeson® Artificial Heart: Promising Results for Heart Failure with Pulmonary Hypertension Medical Innovation Heart Failure Treatment Aeson® Artificial Heart Pulmonary Hypertension Transplant Eligibility
PRESS RELEASE published on 02/17/2025 at 07:00, 1 year 6 months ago Inside Information / Other news releases CARMAT's Aeson® total artificial heart, featured in The Journal of Heart and Lung Transplantation, offers a promising solution for heart failure patients with pulmonary hypertension, potentially becoming a standard treatment Heart Failure CARMAT Aeson® Pulmonary Hypertension Transplant
Published on 09/04/2026 at 23:30, 1 hour 45 minutes ago FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 2 hours 15 minutes ago Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 2 hours 45 minutes ago Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/04/2026 at 14:30, 10 hours 45 minutes ago Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)
Published on 09/04/2026 at 14:00, 11 hours 15 minutes ago Horizon Aircraft Appoints Tom Hearne to Board of Directors and Names Him Audit Committee Chair
Published on 09/04/2026 at 22:10, 3 hours 4 minutes ago Quantinuum to Participate in the Bernstein 23rd Annual Pan-European Strategic Decisions Conference
Published on 09/04/2026 at 19:20, 5 hours 54 minutes ago Dahua Technology Showcases Integrated Smart Living and Innovations at IFA Berlin 2026
Published on 09/04/2026 at 18:50, 6 hours 24 minutes ago A&S Resources secures railway funding of USD$6 Billion to unlock $2.5 trillion iron ore asset
Published on 09/04/2026 at 18:05, 7 hours 9 minutes ago Grundig Unveils New Product Lineup at IFA 2026, Marking a New Phase in Strategic Partnership
Published on 09/04/2026 at 18:57, 6 hours 17 minutes ago Disclosure of transactions in own shares from September 1 to September 4, 2026
Published on 09/04/2026 at 17:45, 7 hours 30 minutes ago Declaration of voting rights at the end of August 2026
Published on 09/04/2026 at 17:45, 7 hours 30 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 09/04/2026 at 16:00, 9 hours 15 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2026
Published on 09/04/2026 at 16:00, 9 hours 15 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2026
